Skip to main content
Clinical Trials/NCT05432011
NCT05432011
Completed
Not Applicable

PENG Block Combined to Lateral Femoral Cutaneous Nerve Block vs. PENG Block Combined to Wound Infiltration for Postoperative Analgesia Following Posterolateral-approached Total Hip Arthroplasty

Campus Bio-Medico University1 site in 1 country50 target enrollmentJuly 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pain
Sponsor
Campus Bio-Medico University
Enrollment
50
Locations
1
Primary Endpoint
Static Pain Score
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study aims to analyze the effect of Pericapsular Nerve Group (PENG) Block combined with lateral femoral cutaneous nerve block vs. PENG block combined with wound infiltration for analgesia after elective hip replacement performed with a posters-lateral approach.

Half of participants will receive a PENG Block combined with femoral lateral cutaneous nerve block, while the other half will receive PENG Block combined with wound infiltration

Registry
clinicaltrials.gov
Start Date
July 1, 2022
End Date
May 25, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Campus Bio-Medico University
Responsible Party
Principal Investigator
Principal Investigator

Giuseppe Pascarella

Principal Investigator

Campus Bio-Medico University

Eligibility Criteria

Inclusion Criteria

  • Elective hip replacement surgery performed with a poster-lateral approach
  • ASA physical status score \< 4

Exclusion Criteria

  • Contraindications to regional anesthesia
  • ASA physical status score ≥ 4
  • Patient's refusal or inability to sign the informed consent
  • Allergies to any drug provided by the study protocol

Outcomes

Primary Outcomes

Static Pain Score

Time Frame: 24 hours

A numerical rating scale (NRS) from 0 (no pain) to 10 (worst imaginable pain) will be used to evaluate pain at rest during 24 hours after surgery

Dynamic Pain Score

Time Frame: 24 hours

A numerical rating scale (NRS) from 0 (no pain) to 10 (worst imaginable pain) will be used to evaluate pain on movement during 24 hours after surgery

Secondary Outcomes

  • Range of hip motion(24 hours)
  • Morphine consumption(6 days)
  • Ability to start physiotherapy during the first postoperative day(24 hours)
  • Quadriceps Strength(24 hours)
  • Ability to ambulate with the help of a walker during the first postoperative day(24 hours)
  • Incidence of block complications(24 hours)
  • Hospital Length of Stay(6 days)

Study Sites (1)

Loading locations...

Similar Trials